News|Articles|February 21, 2024
Upstream Intensification – Enabling Perfusion Processes with Cell Retention Technologies
Author(s)Millipore Sigma
This white paper provides an overview on an enabling cell retention solution resulting in greater cell-mass to achieve significantly higher titers.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
FDA Clears Affinia’s AFTX-201 for Phase I/II BAG3 Cardiomyopathy Trial
3
Cellares Extends Cell Therapy Automation Beyond T Cell Therapies
4
Containment to Protection: Packaging Trends Impacting Biopharma
5